"Bridging patients to better care."
Nimbus received its first FDA 510K approval in 2014 meeting the market's need for a smart, cost effective, electronic ambulatory infusion pump. Our goal was simple and straightforward: develop a non-narcotic pain pump the size of an iPhone with a performance life and reservoir volume to last up to 10 days and offer patients greater control over their pain relief by adding a Demand Bolus PCA function. The first generation PainPRO was launched in the spring of 2015 rapidly catching the attention of thought leading industry experts.
Then leveraging the knowledge and insights of these industry experts, we continued to enhance Nimbus and received a second 510K in 2016 releasing the Nimbus II PainPRO, obtaining DME approval status and expanding on its software based capability to introduce other cutting-edge functionalities.
We've come a long way from the first prototype and the future holds so much more. We will continue to develop new technologies to bring the future of pain management to you today.
Nimbus aims to deliver safe, simple to use, and smart pain management therapy at a cost anyone can afford while refusing to compromise the quality or level of service the industry rightfully demands.
Here at Nimbus, we want to live on the bleeding edge of pain management therapy. We continue to evolve our platform faster than ever to leverage today's tech-centered world and bring a higher level of care to our friends and family.